Pedro Fernández Puentes

Director/Board Member at PHARMA MAR, S.A.

Net worth: 79 M $ as of 2026-06-29

Health Technology

Process Industries

Finance

Profile

Pedro Fernández Puentes currently works at Pharma Mar SA, as Executive Vice Chairman from 1986, Zelnova Zeltia SA, as Chairman, Biofabri SL, as Chairman, Fundacion Menela, as Chairman, Zendal Group, as Chairman, Safoles SA, as Director from 2004, and Sylentis SAU, as Director.
Mr. Fernández Puentes also formerly worked at Zeltia SA, as Vice Chairman from 1971 to 2015, Cooper Zeltia SA, as Chairman & Head-New Product Development Lab from 1965 to 1971, Xylazel SA, as Chairman from 1995 to 1997, CZ Veterinaria SA, as Chairman, Corporación Noroeste SA, as Director, and ICI Zeltia SA, as Director.
Mr. Fernández Puentes received his undergraduate degree from the University of Santiago de Compostela.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
PHARMA MAR SA 5.1%	2025-09-22	917,979 ( 5.1% )	79 M $	2026-06-29

Pedro Fernández Puentes active positions

Companies	Position	Start
PHARMA MAR, S.A.	Director/Board Member	2010-11-16
Biofabri SL Biofabri SL Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products	Chairman	2010-06-02
Zelnova Zeltia SA Zelnova Zeltia SA Chemicals: AgriculturalProcess Industries Prepares and markets insecticides	Chairman	2010-11-16
Fundacion Menela	Chairman	-
Sylentis SA Sylentis SA BiotechnologyHealth Technology Operates as a biotechnology company that focuses on the development of new ophthalmic drugs and novel therapies based on RNAi technology	Director/Board Member	-
Safoles SA Safoles SA Financial ConglomeratesFinance Provides investment services	Director/Board Member	2004-01-01
Zendal Group	Chairman	-

All active positions of Pedro Fernández Puentes

Former positions of Pedro Fernández Puentes

Companies	Position	End
ZELTIA SA	Director/Board Member	2014-12-31
Xylazel SA Xylazel SA Industrial SpecialtiesProcess Industries Manufactures paints, varnishes and allied products	Chairman	1996-12-31
░░░░░░ ░░░░░░ ░░	░░░░░░░░	░░░░░░░░░░
░░░░░░░░░░░░ ░░░░░░░░ ░░	░░░░░░░░░░░░░░ ░░░░░░	-
░░░ ░░░░░░ ░░	░░░░░░░░░░░░░░ ░░░░░░	-

See the detail of Pedro Fernández Puentes's experience

Training of Pedro Fernández Puentes

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Pedro Fernández Puentes's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	14
Safoles SA Safoles SA Financial ConglomeratesFinance Provides investment services	Finance
Zeltia SA Zeltia SA BiotechnologyHealth Technology Operates as a biopharmaceutical company	Health Technology
Cooper Zeltia SA Cooper Zeltia SA Medical/Nursing ServicesHealth Services Provides animal healthcare services	Health Services
Xylazel SA Xylazel SA Industrial SpecialtiesProcess Industries Manufactures paints, varnishes and allied products	Process Industries
Pharma Mar SA Pharma Mar SA Pharmaceuticals: OtherHealth Technology Operates as a biopharmaceutical company	Health Technology
Corporación Noroeste SA Corporación Noroeste SA Construction MaterialsNon-Energy Minerals Manufactures and distributes cement and aggregate products	Non-Energy Minerals
University of Santiago de Compostela University of Santiago de Compostela Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Zelnova Zeltia SA Zelnova Zeltia SA Chemicals: AgriculturalProcess Industries Prepares and markets insecticides	Process Industries
CZ Veterinaria SA CZ Veterinaria SA Pharmaceuticals: MajorHealth Technology Manufactures and distributes animal vaccines	Health Technology
Biofabri SL Biofabri SL Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products	Health Technology
Sylentis SA Sylentis SA BiotechnologyHealth Technology Operates as a biotechnology company that focuses on the development of new ophthalmic drugs and novel therapies based on RNAi technology	Health Technology
Fundacion Menela
ICI Zeltia SA
Zendal Group